Trial Profile
A retrospective study investigating efficacy of suvorexant to treat delirium
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Oct 2016
Price :
$35
*
At a glance
- Drugs Suvorexant (Primary)
- Indications Delirium; Insomnia
- Focus Therapeutic Use
- 10 Oct 2016 New trial record